Slow-acting antirheumatic drugs in chronic arthritis of childhood.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy*; D002648:Child; D004341:Drug Evaluation; D006046:Gold / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D010396:Penicillamine / Q000009:adverse effects / Q000627:therapeutic use; D012074:Remission Induction; D012460:Sulfasalazine / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000962:Antimalarials; D012460:Sulfasalazine; D006046:Gold; D010396:Penicillamine